1. Home
  2. SNOA vs SOPA Comparison

SNOA vs SOPA Comparison

Compare SNOA & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • SOPA
  • Stock Information
  • Founded
  • SNOA 1999
  • SOPA 2018
  • Country
  • SNOA United States
  • SOPA Singapore
  • Employees
  • SNOA N/A
  • SOPA N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • SOPA EDP Services
  • Sector
  • SNOA Health Care
  • SOPA Technology
  • Exchange
  • SNOA Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • SNOA 3.7M
  • SOPA 3.5M
  • IPO Year
  • SNOA 2007
  • SOPA 2021
  • Fundamental
  • Price
  • SNOA $2.53
  • SOPA $0.80
  • Analyst Decision
  • SNOA
  • SOPA Buy
  • Analyst Count
  • SNOA 0
  • SOPA 2
  • Target Price
  • SNOA N/A
  • SOPA $16.00
  • AVG Volume (30 Days)
  • SNOA 366.2K
  • SOPA 30.2K
  • Earning Date
  • SNOA 02-06-2025
  • SOPA 11-15-2024
  • Dividend Yield
  • SNOA N/A
  • SOPA N/A
  • EPS Growth
  • SNOA N/A
  • SOPA N/A
  • EPS
  • SNOA N/A
  • SOPA N/A
  • Revenue
  • SNOA $13,547,000.00
  • SOPA $6,906,240.00
  • Revenue This Year
  • SNOA $23.89
  • SOPA $14.21
  • Revenue Next Year
  • SNOA $25.45
  • SOPA $98.91
  • P/E Ratio
  • SNOA N/A
  • SOPA N/A
  • Revenue Growth
  • SNOA 11.81
  • SOPA N/A
  • 52 Week Low
  • SNOA $2.44
  • SOPA $0.73
  • 52 Week High
  • SNOA $9.40
  • SOPA $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 40.15
  • SOPA 33.17
  • Support Level
  • SNOA $2.61
  • SOPA $0.82
  • Resistance Level
  • SNOA $3.25
  • SOPA $0.95
  • Average True Range (ATR)
  • SNOA 0.21
  • SOPA 0.08
  • MACD
  • SNOA -0.02
  • SOPA -0.01
  • Stochastic Oscillator
  • SNOA 11.11
  • SOPA 11.14

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: